
Dunedin Enterprise Investment Trust PLC
Annual Report and Accounts 2023
Directors’ Report
16
As the Company now has insufficient capital reserves available
to issue B shares for new consideration it is not envisaged that
the Company will issue any further B shares.
Significant Shareholdings
At 31 December 2023 the Company had received notification of
the following holdings of voting rights (under the FCA’s
Disclosure and Transparency Rules):
Ordinary % of issued
shares share capital
Interactive Investor 2,013,138 36.6
Hargreaves Lansdown 800,400 14.5
Asset Value Investors 329,454 6.0
Halifax Share Dealing 226,370 4.1
Lind Invest 213,325 3.9
AJ Bell Securities 173,997 3.2
Directors
Details of the current Directors of the Company are shown on
pages 4 to 5. All Directors are considered to be independent. No
contract or arrangement existed during the period in which any
of the Directors had a material interest. No Director has a service
contract with the Company. Following a detailed review by the
Board of each of the Directors other commitments, both public
and private, it is considered that each has sufficient time
available to undertake their duties as a Director of the Company.
In accordance with the UK Corporate Governance Code,
changes to the Chairman’s other significant commitments require
to be disclosed and explained. The Chairman’s other
directorships are noted on page 4. The Directors have carefully
considered the Chairman’s other directorships and consider that
the Chairman effectively manages his commitments and has
sufficient time to meet what is expected of him as Chairman of
the Company. The Chairman’s attendance at Board and
Committee meetings is outlined in the relevant table on page 20.
The table shows that the Chairman has attended each Board and
Committee meeting held during the year. The Directors believe
this demonstrates that the Chairman continues to allocate
sufficient time to the Company and continues to discharge his
responsibilities effectively.
Angela Lane, Duncan Budge and Brian Finlayson will retire from
the Board and, being eligible, offer themselves for re-election at
the Annual General Meeting (“AGM”).
Duncan Budge is a non-executive director of Asset Value
Investors. Clients of Asset Value Investors are significant
shareholders in the Company. Duncan Budge has no role in the
investment decisions of Asset Value Investors. The Directors do
not consider that there are relationships or circumstances which
are likely to affect Duncan Budge’s judgement.
Brian Finlayson was appointed to the Board on 1 January 2007
and has served for more than nine years. He has over thirty years
of experience in both private equity and corporate finance. He
worked with Dunedin Capital Partners Limited before retiring
from the company in 2002. He has held numerous non-executive
director positions in private equity backed businesses both whilst
unlisted and subsequently on listing. The Directors have carefully
considered Brian Finlayson’s independence and believe that
notwithstanding his historic connections with the Manager’s
group and the number of years he has served as a Director, he
retains independence of character and of judgement. The
Directors do not consider that there are relationships or
circumstances which are likely to affect Brian Finlayson’s
judgement. Given the long-term nature of private equity
investments the Board considers it a significant benefit to the
Company for Directors of the Company not to be subject to any
overall limit on tenures.
Following performance evaluation, in the view of the other
Directors, Angela Lane, Duncan Budge and Brian Finlayson
continue to perform effectively and to demonstrate commitment
to the Company. The re-election of Angela Lane, Duncan Budge
and Brian Finlayson is recommended to shareholders as their
skills and experience continue to add to the strength of the
Board.
Tenure of the Chairman
Duncan Budge has been a Director of the Company since 2 April
2012 and Chairman since 14 May 2014. The Nomination
Committee has resolved that it is in the best interests of the
Company that there should be no limit on the length of tenure of
the Chairman; however, this position will be subject to annual
review. The Nomination Committee took a number of factors into
consideration when arriving at this conclusion, including the fact
that private equity investments by their nature are long term
investments where an accumulated knowledge of the
investments is beneficial to their supervision. Additionally, the
Company is in a wind-down process which was approved by
shareholders in May 2016. At the time the wind-down was
approved, the Directors indicated that the process would take at
least seven years to complete and the Nomination Committee
consider it beneficial for there to be consistency of chairmanship
during this period.
Directors’ and Officers’ Liability Insurance/Directors’
Indemnity
The Company maintains insurance in respect of directors’
liabilities in relation to their acts on behalf of the Company.
In line with market practice and the Company’s Articles of
Association, the Company has agreed to indemnify the Directors
in respect of costs, charges, liabilities, damages and expenses,
arising out of any claims or proposed claims made for
negligence, default, breach of duty, breach of trust or otherwise,
or relating to any application under section 1157 of the 2006 Act,
in connection with the performance of their duties as Directors of
the Company. The indemnities would also provide financial
support from the Company should the level of cover provided by
the Directors’ & Officers’ insurance maintained by the Company
be exhausted.
Directors’ Conflicts of Interest
Under the 2006 Act, a Director must avoid a situation where he
has, or can have, a direct or indirect interest that conflicts, or
possibly may conflict, with the Company’s interests. The 2006
Act allows directors of public companies to authorise conflicts
and potential conflicts, where appropriate, where the articles of
association contain provisions to this effect. The Company’s
Articles of Association give the Directors authority to approve
such situations.
The Company maintains a register of Directors’ conflicts of
interest which have been disclosed and approved by the other
Directors. The register is reviewed at each Board meeting and
the Directors are required to disclose to the Company Secretary
any change to conflicts or any potential new conflicts. Where a
conflict of interest arises, the Director concerned will not
participate in any discussions or decisions in that area.